COVID-19 Testing for the Essential Workforce

Learn about our efforts to test people on the front line and how you can help.

NEWS

Posts

Breast cancer ribbon in doctors hands

Breast Cancer Awareness Month

It’s Breast Cancer Awareness Month, so here at MiraKind, we’re taking a moment to think about the many ways in which breast cancer impacts our community.  Many of you may know that…

Read More
Woman smiling Menopause

Menopause & Myths about Hormone Replacement Therapy

For the large majority of us who suffer one or more symptoms of menopause, we can all agree that it is NO FUN.  So what can we do about it? According to…

Read More
Test tubes

What You Need to Know About Estrogen and the KRAS-variant

Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation which predicts an increased risk of cancer. Following this breakthrough, Weidhaas and her…

Read More
Woman thinking about menopause

Let’s Talk Menopause (Finally)

Menopause: a condition that 100% of women will experience, yet so few of us feel comfortable talking about. We all know something about menopause, but just like pregnancy or bungee jumping, you…

Read More
Miradx Patient

Why you should get your KRAS-variant results

Dear study participants, I wanted to share an experience that I had today. I had a wonderful conversation with a woman who participated in the first MiraKind study.  While I always enjoy…

Read More
Test sample in lab

The truth about GWAS and the KRAS-variant

Although much of the world has accepted that GWAS studies, which use an outdated technology looking at large amounts of data, have failed to find any functional mutations, this approach has twice…

Read More
Dr. Joanne Weidhaas

How does breast cancer treatment impact second breast cancer risk?

We are embarking on a study to explore how breast cancer management strategies (e.g., chemotherapy, surgery, hormones) that are used to treat breast cancer, impact breast cancer risk for women with the KRAS-variant.

Read More

DONATE

SUPPORT OUR RESEARCH

PARTICIPATE

HELP ADVANCE OUR RESEARCH